Xenon Pharmaceuticals Inc. (XENE) Climbed 6.17% or 0.25 To Price $4.3 On Wednesday


Xenon Pharmaceuticals Inc. (XENE) climbed 6.17% or 0.25 to $4.3. It is close to 75000 shares traded, which is 106.4% compare to the average total volume 70486. The market cap of XENE is $77.39 million. The year to date change is 40.87%. The 52 week price range is from $2.1 to $9.95. Price of XENE have changed 8.00% during last week. It have changed 22.73% over last month, 68.75% over last 3 months, 26.56% over last 6 months and -50.61% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for XENE is 3.25. It is -24.42% below current price. The 200-day Moving Averages for XENE is 3.15. It is -26.74% below current price. The 52-week High is 9.95. It is 131.40% from the current price. The 52-week Low is 2.1. It is -51.16% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of XENE is 3.15 on 2018-02-15. Short % to float is 1.12%. There are some statistics of XENE. It is has market cap $77.39 million. The share outstanding is 18.00 million. The average volume is 70486. The revenue is 671000. The percent of top 15 Institution holding is 34.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of XENE is -49.52%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of XENE is -46.58%.


Tags:

Share this post